相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases
Yunlong Lu et al.
CHEMICAL SOCIETY REVIEWS (2022)
Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment
Ying Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Water-Soluble Gold(III)-Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells
Jong Hyun Kim et al.
CHEMMEDCHEM (2021)
Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity
Mianli Bian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells
Sreeja Dattachoudhury et al.
ONCOLOGY (2020)
Anticancer Gold(III) Compounds With Porphyrin or N-heterocyclic Carbene Ligands
Ka-Chung Tong et al.
FRONTIERS IN CHEMISTRY (2020)
Advances in alkynyl gold complexes for use as potential anticancer agents
Zhibin Yang et al.
COORDINATION CHEMISTRY REVIEWS (2020)
Synergistic Activity of Paclitaxel Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer
Kyung Hwa Choi et al.
TRANSLATIONAL ONCOLOGY (2019)
Targeting the Thioredoxin System as a Strategy for Cancer Therapy
Mianli Bian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?
Chien Ing Yeo et al.
MOLECULES (2018)
Proteasome versus Thioredoxin Reductase Competition as Possible Biological Targets in Antitumor Mixed Thiolate-Dithiocarbamate Gold(III) Complexes
Javier Quero et al.
INORGANIC CHEMISTRY (2018)
Cyclometallated Au(iii) dithiocarbamate complexes: synthesis, anticancer evaluation and mechanistic studies
Morwen R. M. Williams et al.
METALLOMICS (2018)
In Vitro and In Vivo Investigations into the Carbene Gold Chloride and Thioglucoside Anticancer Drug Candidates NHC-AuCl and NHC-AuSR
Wolfgang Walther et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2017)
Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
Ramin Rezaee et al.
PHARMACOLOGICAL RESEARCH (2017)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(I) N-heterocyclic carbene complexes
R. McCall et al.
CHEMICAL SCIENCE (2017)
Investigations on Binding Pattern of Kinase Inhibitors with PPARγ : Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies
Mohit Mazumder et al.
PPAR RESEARCH (2017)
Auranofin, Et3PAuCl, and Et3PAul Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study
Tiziano Marzo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Platinum-based drugs: past, present and future
Shahana Dilruba et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Deubiquitinases as Anticancer Targets of Gold Complexes
Taotao Zou et al.
ISRAEL JOURNAL OF CHEMISTRY (2016)
Enhanced anti-cancer activities of a gold(III) pyrrolidinedithiocarbamato complex incorporated in a biodegradable metal-organic framework
Raymond Wai-Yin Sun et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Preconditioning is hormesis part I: Documentation, dose-response features and mechanistic foundations
Edward J. Calabrese
PHARMACOLOGICAL RESEARCH (2016)
Phosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer
Bin Wang et al.
SPRINGERPLUS (2016)
Data Warrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Thomas Sander et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder et al.
DRUGS IN R&D (2015)
Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
Stanleyson V. Hato et al.
CLINICAL CANCER RESEARCH (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Synthesis and cytotoxic activity of gold(I) complexes containing phosphines and 3-benzyl-1,3-thiazolidine-2-thione or 5-phenyl-1,3,4-oxadiazole-2-thione as ligands
Joana Darc S. Chaves et al.
INORGANICA CHIMICA ACTA (2014)
被撤回的出版物: Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer (Retracted article. See vol. 23, 2022)
Babita Shashni et al.
BMC GENOMICS (2013)
Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
A dinuclear cyclometalated gold(III)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo
Raymond Wai-Yin Sun et al.
CHEMICAL SCIENCE (2013)
A dual cytotoxic and anti-angiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells
Jing-Jing Zhang et al.
CHEMICAL COMMUNICATIONS (2012)
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties
Laura Maiore et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
The biological activity of auranofin: implications for novel treatment of diseases
J. M. Madeira et al.
INFLAMMOPHARMACOLOGY (2012)
Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes
Krishna P. Bhabak et al.
DALTON TRANSACTIONS (2011)
A review of the logistic role of l-carnitine in the management of radiation toxicity and radiotherapy side effects
Haseeb Ahmad Khan et al.
JOURNAL OF APPLIED TOXICOLOGY (2011)
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Alberto Bindoli et al.
COORDINATION CHEMISTRY REVIEWS (2009)
The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes
Luca Ronconi et al.
DALTON TRANSACTIONS (2009)
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Stefania Nobili et al.
MEDICINAL RESEARCH REVIEWS (2009)
Gold(III) compounds as anticancer agents: Relevance of gold-protein interactions for their mechanism of action
Angela Casini et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Cellular and molecular consequences of peroxisome proliferator-activated receptor-γ activation in ovarian cancer cells
Sara Vignati et al.
NEOPLASIA (2006)
Anticancer cyclometalated [AuIII m(C∧N∧C)mL]n+ compounds:: Synthesis and cytotoxic properties
Carrie Ka-Lei Li et al.
CHEMISTRY-A EUROPEAN JOURNAL (2006)
The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells
SJ Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats
SY Saad et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2004)
Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators
S Theocharis et al.
CANCER TREATMENT REVIEWS (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Reactions of gold(III) complexes with serum albumin
G Marcon et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells
CM Che et al.
CHEMICAL COMMUNICATIONS (2003)
Gold(III) complexes with bipyridyl ligands: Solution chemistry, cytotoxicity, and DNA binding properties
G Marcon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
分享论文
